Erythropoietin in Premature Infants to Prevent Encephalopathy

Status Terminated

Clinical Trial Summary

The main goal of this trial is to investigate whether early administration of human erythropoietin (EPO) in preterm infants improves neurodevelopmental outcome at 18 months corrected age. This study is designed as randomized, double-masked, placebo controlled multicenter study involving at least 312 patients.

Clinical Trial Description

EPO has been safely used for prevent preterm anemia and recent studies have shown the neuro-protective effect. Our hypothesis is that EPO could prevent preterm brain injury and reduce the rate of premature death and disability from encephalopathy. The aims of this study include: to investigate the safety and efficacy of EPO by using 1000u/kg higher than the dose of anemia treatment (250u/kg); to evaluate the effect of EPO on neurodevelopment in preterm infants; to detect biological and imaging indicators of EPO. Eligible premature infants will be enrolled in this double-blind, placebo-controlled randomized trial from the neonatal neurological intensive care unit (NNICU) at 7 Children's Hospital in 6 provinces of China. Subjects will be enrolled within the first 24 hours of life and randomly assigned to receive Epo or saline vehicle placebo. Standard NICU care will be provided to all subjects. Pharmacokinetic data, serial brain electrophysiologic and imaging exams, circulating inflammatory mediators, biomarkers and complications like polycythemia, neutropenia, thrombocytopenia, hypertension, sepsis, hemorrhage, seizure, necrotizing enterocolitis (NEC), persistent ductus arterious (PDA), apnea of prematurity, pulmonary haemorrhage, pulmonary hypertension, Prolonged blood coagulation time, retinopathy of prematurity (ROP), cardiac arrhythmia, major venous thrombosis, Renal failure treated with dialysis, pneumonia, pulmonary airleak and chronic lung disease will be collected at established time points during the study period. At 18 months corrected age, subjects will undergo a neurodevelopmental evaluation assessing for cerebral palsy, Bayley Scores of Mental Development Index (MDI) use. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02550054
Study type	Interventional
Source	Children's Hospital of Fudan University
Contact
Status	Terminated
Phase	Phase 2
Start date	September 8, 2015
Completion date	December 30, 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03827252` - Respiratory Stability and Vegetative Coupling During Neonatal Skin-to-skin Care
Active, not recruiting	`NCT03345069` - Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)
Completed	`NCT04067206` - The Effects Of Auditory Interventions On Pain And Comfort In Premature Infants	N/A
Completed	`NCT03911674` - Effects of Oral Stimulation in Preterm Infants	Phase 3
Completed	`NCT03324126` - Individualized Fortification of Breast Milk	N/A
Completed	`NCT03704012` - Efficacy of Massage Applied by the Parents in Hospitalized Premature Birth (PreMas)	N/A
Active, not recruiting	`NCT03241082` - Ultrasound Assessment of BC in the NICU
Completed	`NCT03701906` - Effect of a Mixture of New Probiotic Strains in Preterm Infants	N/A
Completed	`NCT02133716` - Efficacy of Breast Milk Expressed and Sucrose in Procedural Pain in Preterm	Phase 4
Not yet recruiting	`NCT05543005` - Efficacy Study of an Audio Device Outside Incubator Allowing Broadcasting Maternal Voice on Stability in Preterm Infants	N/A
Recruiting	`NCT03852641` - Feeding Premature Infants During Non-invasive Respiratory Support	N/A
Active, not recruiting	`NCT03423914` - Efficacy of Expressive Writing in Mothers of Preterm Infants	N/A
Recruiting	`NCT04648787` - A Study of Family-integrated Care for Reducing Uncertainty	N/A
Recruiting	`NCT04866342` - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor	N/A
Not yet recruiting	`NCT02534090` - Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy	N/A
Not yet recruiting	`NCT02601872` - Erythropoietin in Premature Infants to Prevent Encephalopathy	Phase 2
Recruiting	`NCT06212427` - Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)	N/A
Suspended	`NCT03939169` - The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP)	N/A
Completed	`NCT03706586` - The Hilo Pilot -Trial to Assess Feasibility	N/A
Completed	`NCT03726697` - Effect of Tahneek on Hypoglycemia in Newborn Infants	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.